Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
The Journal of Toxicological Sciences|March 31, 2024
Transcriptome analysis of cultured human vascular endothelial cells after γ-ray irradiation and correlation analysis with ATP, ADP, and adenosine as secondary soluble factorsTomoya Fujie, Miyabi Kobayashi, Lihito Ikeuchi, et al.Biochemical and Biophysical Research Communications|June 15, 2013
Cleavage of the interchain disulfide bonds in rituximab increases its affinity for FcγRIIIAMami Suzuki, Ayaka Yamanoi, Yusuke Machino, et al.European Journal of Pharmacology|September 18, 2012
Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7Fumie Hattori, Yasuhiro Ohshima, Shizuka Seki, et al.Journal of Neurochemistry|March 15, 2011
The activation of P2X7 receptor induces cathepsin D-dependent production of a 20-kDa form of IL-1β under acidic extracellular pH in LPS-primed microglial cellsTakato Takenouchi, Yoshifumi Iwamaru, Shuei Sugama, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
The activation of P2X7 receptor impairs lysosomal functions and stimulates the release of autophagolysosomes in microglial cellsTakato Takenouchi, Masaaki Nakai, Yoshifumi Iwamaru, et al.Medicines (Basel, Switzerland)|April 3, 2021
A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE SignalingHideaki Abe, Miwa Okazawa, Takahiro Oyama, et al.Biological & Pharmaceutical Bulletin|December 22, 2024
Amodiaquine Analogs Are Potent Inhibitors of Interleukin-6 Production Induced by Activation of Toll-Like Receptors Recognizing Pathogen Nucleic AcidsYohei Takenaka, Tomohiro Tanaka, Shotaro Otaki, et al.Anticancer Research|December 30, 2023
Luminal B Breast Cancer Coexpressing <i>p62</i> and <i>ALDH1A3</i> Is Less Susceptible to RadiotherapyAyaka Ozaki, Akari Matsuda, Yuki Maemura, et al.Biochemical and Biophysical Research Communications|June 10, 2021
A 3-styrylchromone converted from trimebutine 3D pharmacophore possesses dual suppressive effects on RAGE and TLR4 signaling pathwaysMiwa Okazawa, Takahiro Oyama, Hideaki Abe, et al.Pageof 9